Document is current
Any future updates will be listed below
-
Authors
Järveläinen, Niko
Halonen, Paavo J.
Nurro, Jussi
Kuivanen, Antti
Pajula, Juho
Tarkia, Miikka
Grönman, Maria
Saraste, Antti
Laakkonen, Johanna
Toivanen, Pyry
Nieminen, Tiina
Rissanen, Tuomas T.
Knuuti, Juhani
Ylä-Herttuala, Seppo
- License Information
-
More Information
Article History
Received: 19 October 2023
Accepted: 28 November 2024
First Online: 3 December 2024
Declarations
:
: NJ is a shareholder of Saparo Translational Research Oy, a CRO for large animal studies.
: The Finnish National Animal Experiment Board and the Animal Experiment Board of the University of Finland approved all animal experiments. All animal experiments were in compliance with the ARRIVE guidelines. People involved in animal work have Felasa B or C certification.
